C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 811.00
-14.00 (-1.70%)
At close: Mar 12, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 46.78 billion as of March 13, 2026. Its market cap has decreased by -23.36% in one year.
Market Cap
46.78B
Enterprise Value
41.47B
Revenue
63.97B
Ranking
n/a
PE Ratio
16.56
Stock Price
811.00
Market Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 3.81B to 46.78B, an increase of 1,127.84%. That is a compound annual growth rate of 80.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 46.78B | -9.56% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 2,744.60% |
| Dec 9, 2021 | 3.81B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 1.02T |
| DreamCIS | 126.57B |
| HLB bioStep | 103.22B |
| P&K Skin Research Center | 62.96B |
| WOOJUNG BIO | 60.67B |
| DT&CRO CO. | 39.50B |
| SLS BIO | 26.89B |
| BioInfra | 19.46B |